Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

PaperCitations, authors & open-access status

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 103 citations, 2024 year and green oa status.